Provided By GlobeNewswire
Last update: Mar 21, 2025
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORONTO, March 21, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF) (“Conavi” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, is pleased to provide an update in respect of its previously announced public offering (the “Offering”). The Company expects that the Offering will now proceed as an offering of common shares of the Company (“Common Shares”) (or pre-funded common share purchase warrants (“Pre-Funded Warrants” and, together with the Common Shares, the “Securities”) of the Company in lieu of Common Shares). The number of Securities to be distributed, the price of each Security and the size of the Offering will be determined by negotiation between the Company and the Agent (as defined below) in the context of the market with final terms to be determined at the time of pricing.
Read more at globenewswire.com